117 related articles for article (PubMed ID: 19827649)
1. [Treatment of patients with hypertriglyceridemia].
Rozhkova TA; Kukharchuk VV; Titov VN; Iarovaia EB; Kotova LA; Malyshev PP; Ameliushkina VA
Ter Arkh; 2009; 81(9):29-33. PubMed ID: 19827649
[TBL] [Abstract][Full Text] [Related]
2. [The effect of micronized phenofibrate on the lipoproteins of the blood plasma at different initial lipid levels].
Perova NV; Ozerova IN; Kalinina AM; Pavlova LI; Olfer'ev AM; Mel'kina OE; Golubev MA; Oganov RG
Ter Arkh; 1996; 68(1):71-6. PubMed ID: 8644040
[TBL] [Abstract][Full Text] [Related]
3. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
Grundy SM; Vega GL; Tomassini JE; Tershakovec AM
Am J Cardiol; 2009 Aug; 104(4):548-53. PubMed ID: 19660610
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostics of moderate and high hypertriglyceridemia in patients in polyclinic practice: primary and secondary lipid metabolic disorders].
Rozhkova TA; Titov VN; Ameliushkina VA; Iarovaia EB; Malyshev PP; Meshkov AN; Kukharchuk VV
Ter Arkh; 2010; 82(4):10-7. PubMed ID: 20481208
[TBL] [Abstract][Full Text] [Related]
5. [Acipimox (Olbetam) as a secondary hypolipemic agent in combined hypertriglyceridemia and hyperlipidemia].
Yeshurun D; Hamood H; Morad N; Naschitz J
Harefuah; 2000 Apr; 138(8):650-3, 710. PubMed ID: 10883206
[TBL] [Abstract][Full Text] [Related]
6. Possible role of ubiquinone in the treatment of massive hypertriglyceridemia resistant to PUFA and fibrates.
Cicero AF; Derosa G; Miconi A; Laghi L; Nascetti S; Gaddi A
Biomed Pharmacother; 2005 Jul; 59(6):312-7. PubMed ID: 15932792
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus-induced elevation in plasma triglyceride concentrations after administration to renal transplant patients is partially due to a decrease in lipoprotein lipase activity and plasma concentrations.
Tory R; Sachs-Barrable K; Goshko CB; Hill JS; Wasan KM
Transplantation; 2009 Jul; 88(1):62-8. PubMed ID: 19584682
[TBL] [Abstract][Full Text] [Related]
8. Heparin treatment for severe hypertriglyceridemia in diabetic ketoacidosis.
Cole RP
Arch Intern Med; 2009 Aug; 169(15):1439-41. PubMed ID: 19667310
[TBL] [Abstract][Full Text] [Related]
9. [Use of drug therapy in hyperlipidemia in patients after myocardial infarct in the Czech Republic].
Widimský J; Lánská V; Jurán F; Leisser J; Vanĕk P; Spírek A; Koval Z
Vnitr Lek; 1997 Apr; 43(4):191-4. PubMed ID: 9601832
[TBL] [Abstract][Full Text] [Related]
10. High doses of bifendate elevate serum and hepatic triglyceride levels in rabbits and mice: animal models of acute hypertriglyceridemia.
Pan SY; Yang R; Han YF; Dong H; Feng XD; Li N; Geng W; Ko KM
Acta Pharmacol Sin; 2006 Jun; 27(6):673-8. PubMed ID: 16723084
[TBL] [Abstract][Full Text] [Related]
11. The effect of prescription omega-3 fatty acids on body weight after 8 to 16 weeks of treatment for very high triglyceride levels.
Bays HE; Maki KC; Doyle RT; Stein E
Postgrad Med; 2009 Sep; 121(5):145-50. PubMed ID: 19820283
[TBL] [Abstract][Full Text] [Related]
12. Paradoxical decreases in high-density lipoprotein cholesterol with fenofibrate: a quite common phenomenon.
Magee G; Sharpe PC
J Clin Pathol; 2009 Mar; 62(3):250-3. PubMed ID: 19251953
[TBL] [Abstract][Full Text] [Related]
13. L-Arginine enhances the triglyceride-lowering effect of simvastatin in patients with elevated plasma triglycerides.
Schulze F; Glos S; Petruschka D; Altenburg C; Maas R; Benndorf R; Schwedhelm E; Beil U; Böger RH
Nutr Res; 2009 May; 29(5):291-7. PubMed ID: 19555809
[TBL] [Abstract][Full Text] [Related]
14. [Effect of phenofibrate treatment on endothelial dysfunction in patients with history of myocardial infarction in young age].
Berkovich OA; Bazhenova EA; Volkova EV; Tolstova IA; Alugishvili MZ; Shliakhto EV
Ter Arkh; 2002; 74(1):43-7. PubMed ID: 11878058
[TBL] [Abstract][Full Text] [Related]
15. [A trial of the use of the hypolipidemic preparation Lipanor (ciprofibrate) in patients with primary hyperlipidemia].
Kukharchuk VV; Rozhkova TA; Kotova LA; Tvorogova MG; Semenova OA
Ter Arkh; 1996; 68(6):58-61. PubMed ID: 8771689
[TBL] [Abstract][Full Text] [Related]
16. Unexpected and abnormally low HDL cholesterol levels on combination hypolipidemic therapy.
Unnikrishnan R; Das R; Jaydip R; Sudhakaran C; Mohan V
J Assoc Physicians India; 2009 Feb; 57():180-1. PubMed ID: 19582991
[TBL] [Abstract][Full Text] [Related]
17. Possible risk factor for postmenopausal women: postprandial hypertriglyceridemia.
Yoshikata R; Miyahara Y; Onoe Y; Okano H; Ohta H
J Obstet Gynaecol Res; 2008 Dec; 34(6):1032-6. PubMed ID: 19012704
[TBL] [Abstract][Full Text] [Related]
18. Plasmapheresis for severe lipemia: comparison of serum-lipid clearance rates for the plasma-exchange and double-filtration variants.
Yeh JH; Lee MF; Chiu HC
J Clin Apher; 2003; 18(1):32-6. PubMed ID: 12717791
[TBL] [Abstract][Full Text] [Related]
19. Hospital use and medical care costs up to 5 years after triglyceride lowering among patients with severe hypertriglyceridemia.
Nichols GA; Arondekar B; Jacobson TA
J Clin Lipidol; 2012; 6(5):443-9. PubMed ID: 23009780
[TBL] [Abstract][Full Text] [Related]
20. Bridging the gap in treatment options for patients with hypertriglyceridemia.
Underberg JA; Hays R
J Fam Pract; 2007 Dec; 56(12 Suppl New):S24-31. PubMed ID: 18664339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
